Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study.
Inflammatory cortical demyelination in early multiple sclerosis.
The INCAT disability score: A critical analysis of its measurement properties.
Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies.
Interferon beta for secondary progressive multiple sclerosis.
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting
Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.
Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe
Translating Fatigue to Human Performance.
Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing-Remitting Multiple Sclerosis.
Inflammation-induced fatigue: Exploring neurobiological mechanisms and potential treatments
Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study.
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Characterization of CD56bright NK cells in daclizumab HYP-treated RRMS patients
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
Receptos doses first patient in Phase 2 trial for RPC1063 in ulcerative colitis
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.
Interferon β-1b directly modulates human neural stem/progenitor cell fate.
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.

Pages